Changes in the Pacemaker Rate after Transition from Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation the Critical Role of Valve Implantation Height

JACC: Cardiovascular Interventions

Volumn 9, Issue 8, 2016, Pages 805-813

  De Torres Alba, Fernando ^a   Kaleschke, Gerrit ^a   Diller, Gerhard Paul ^a   Vormbrock, Julia ^a   Orwat, Stefan ^a   Radke, Robert ^a   Reinke, Florian ^a   Fischer, Dieter ^a   Reinecke, Holger ^a   Baumgartner, Helmut ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

balloon expandable valve; conduction abnormalities; Edwards SAPIEN 3; pacemaker; transcatheter aortic valve replacement

Indexed keywords

AGED; AREA UNDER THE CURVE; ARTICLE; ATRIOVENTRICULAR BLOCK; COMPARATIVE STUDY; EUROSCORE; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART LEFT BUNDLE BRANCH BLOCK; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; IMPLANTED HEART PACEMAKER; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; PACEMAKER IMPLANTATION; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; PROPENSITY SCORE; RECEIVER OPERATING CHARACTERISTIC; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SEX DIFFERENCE; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; ARTIFICIAL HEART PACEMAKER; CHI SQUARE DISTRIBUTION; DEVICES; DIAGNOSTIC IMAGING; HEART CATHETERIZATION; HEART PACING; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS DESIGN; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; CARDIAC CATHETERIZATION; CARDIAC PACING, ARTIFICIAL; CHI-SQUARE DISTRIBUTION; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PACEMAKER, ARTIFICIAL; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84963857327     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.12.023     Document Type: Article

References (23)

1. M.B. Leon, C.R. Smith, M. Mack, and et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
2. C.R. Smith, M.B. Leon, M.J. Mack, and et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
3. M. Urena, M. Mok, V. Serra, and et al. Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve J Am Coll Cardiol 60 2012 1743 1752
4. Ö. Aktug, G. Dohmen, K. Brehmer, and et al. Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation Int J Cardiol 160 2012 26 30
5. A. Laynez, I. Ben-Dor, I.M. Barbash, and et al. Frequency of conduction disturbances after Edwards SAPIEN percutaneous valve implantation Am J Cardiol 110 2012 1164 1168
6. M. Urena, J.G. Webb, A. Cheema, and et al. Impact of new-onset persistent left bundle branch block on late clinical outcomes in patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve J Am Coll Cardiol Intv 7 2014 128 136
7. P. Houthuizen, R.M. van der Boon, M. Urena, and et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation EuroIntervention 9 2014 1142 1150
8. M.Z. Khawaja, R. Rajani, A. Cook, and et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative) Circulation 123 2011 951 960
9. K. Czerwińska, T. Hryniewiecki, A. Orȩziak, and et al. [Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience] Kardiol Pol 70 2012 121 128
10. G.C.M. Siontis, P. Jüni, T. Pilgrim, and et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis J Am Coll Cardiol 64 2014 129 140
11. M. Abdel-Wahab, J. Mehilli, C. Frerker, and et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial JAMA 311 2014 1503 1514
12. C. Fraccaro, G. Buja, G. Tarantini, and et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation Am J Cardiol 107 2011 747 754
13. J.J. Bax, V. Delgado, V. Bapat, and et al. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation Eur Heart J 35 2014 2639 2654
14. J. Webb, G. Gerosa, T. Lefèvre, and et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve J Am Coll Cardiol 64 2014 2235 2243
15. T.M. Nazif, J.M. Dizon, R.T. Hahn, and et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry J Am Coll Cardiol Intv 8 2015 60 69
16. R.M.A. Van der Boon, P. Houthuizen, M. Urena, and et al. Trends in the occurrence of new conduction abnormalities after transcatheter aortic valve implantation Catheter Cardiovasc Interv 85 2015 144 152
17. M. Brignole, A. Auricchio, G. Baron-Esquivias, and et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association Eur Heart J 34 2013 2281 2329
18. M.B. Leon, N. Piazza, E. Nikolsky, and et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
19. G. Athappan, E. Patvardhan, E.M. Tuzcu, and et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature J Am Coll Cardiol 61 2013 1585 1595
20. L. Buellesfeld, S. Stortecky, D. Heg, and et al. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation J Am Coll Cardiol 60 2012 493 501
21. G. Mouillet, N. Lellouche, M. Yamamoto, and et al. Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve(®) devices: results from the FRANCE 2 Registry Catheter Cardiovasc Interv 86 2015 E158 E166
22. G. Tarantini, M. Mojoli, P. Purita, and et al. Unravelling the (arte)fact of increased pacemaker rate with the Edwards SAPIEN 3 valve EuroIntervention 11 2015 343 350
23. A.W. Leber, W. Eichinger, J. Rieber, and et al. MSCT guided sizing of the Edwards Sapien XT TAVI device: impact of different degrees of oversizing on clinical outcome Int J Cardiol 168 2013 2658 2664